When imiquimod fails

Dermatologic Surgery

Volumn 36, Issue 5, 2010, Pages 717-720

  Firoz, Bahar F ^a   Goldberg, Leonard H ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ANAMNESIS; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CASE REPORT; CHEMOSURGERY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHEMA; FITZPATRICK SKIN TYPE IV; FULL THICKNESS SKIN GRAFT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SKIN NECROSIS; TUMOR VOLUME;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY; CARCINOMA, BASAL CELL; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; MIDDLE AGED; MOHS SURGERY; SKIN NEOPLASMS; SKIN TRANSPLANTATION; TIME FACTORS; TREATMENT FAILURE;

EID: 77951261527     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01536.x     Document Type: Article

References (18)

1. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2002 43 : S6 11.
2. Pazdur R, Keegan P. FDA Approval for Imiquimod [on-line]. Available at : Accessed April 4, 2009.
3. Szemies RM, Gerritsen MJ, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle controlled clinical trial with histology. JAAD 2004 51 : 547 555.
4. Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle controlled studies. J Am Acad Dermatol 2004 50 : 722 733.
5. Eigentler TK, Kamin A, Weide BM. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007 57 : 616 621.
6. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease: 2006 update. Therapy guidelines and audit subcommittee, British Association of Dermatologists. Br J Dermatol 2007 156 : 11 21.
7. National Health and Medical Research Council (Australia) & Australia Cancer Network Non-Melanoma Skin Cancer Working Party, 2003. Clinical practice guidelines, non-melanoma skin cancer : guidelines for treatment and management in Australia. Available at: http://www.nhmrc.gov.au/publications/pdf/cp87.pdf.
8. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol 2006 126 : 1251 1255.
9. Holmkvist KA, Rogers GS, Dahl PR. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy. J Am Acad Dermatol 1999 41 : 600 605.
10. Murphy ME, Brodland DG, Zitelli JA. Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series. Dermatol Surg 2008 34 : 1258 1263.
11. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989 15 : 315 328.
12. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 2003 148 : 195 202.
13. Schiessl C, Wolber C, Tauber M, et al. Treatment of all basal cell carcinoma variants including large and high-risk lesions with imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drug Dermatol 2007 6 : 507 513.
14. Sterry W, Ruzicka T, Herrera E, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002 147 : 1227 1236.
15. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Arch Dermatol 2002 138 : 1165 1171.
16. Rapini RP. Comparison of methods for checking surgical margins. J Am Acad Dermatol 1990 23 (2 Pt 1) : 288 294.
17. Kimyai-Asadi A, Goldberg LH, Jih M. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen. J Am Acad Dermatol 2005 53 : 469 474.
18. Alam M, Goldberg LH, Silapunt S, et al. Delayed treatment and continued growth of non-melanoma skin cancer, JAAD, in press.